Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis
Andreas Prokesch, Franziska A Graef, Tobias Madl, Jennifer Kahlhofer, Steffi Heidenreich, Anne Schumann, Elisabeth Moyschewitz, Petra Pristoynik, Astrid Blaschitz, Miriam Knauer, Matthias Muenzner, Juliane G Bogner-Strauss, Gottfried Dohr, Tim J Schulz, Michael Schupp, Andreas Prokesch, Franziska A Graef, Tobias Madl, Jennifer Kahlhofer, Steffi Heidenreich, Anne Schumann, Elisabeth Moyschewitz, Petra Pristoynik, Astrid Blaschitz, Miriam Knauer, Matthias Muenzner, Juliane G Bogner-Strauss, Gottfried Dohr, Tim J Schulz, Michael Schupp
Abstract
The ability to adapt cellular metabolism to nutrient availability is critical for survival. The liver plays a central role in the adaptation to starvation by switching from glucose-consuming processes and lipid synthesis to providing energy substrates like glucose to the organism. Here we report a previously unrecognized role of the tumor suppressor p53 in the physiologic adaptation to food withdrawal. We found that starvation robustly increases p53 protein in mouse liver. This induction was posttranscriptional and mediated by a hepatocyte-autonomous and AMP-activated protein kinase-dependent mechanism. p53 stabilization was required for the adaptive expression of genes involved in amino acid catabolism. Indeed, acute deletion of p53 in livers of adult mice impaired hepatic glycogen storage and induced steatosis. Upon food withdrawal, p53-deleted mice became hypoglycemic and showed defects in the starvation-associated utilization of hepatic amino acids. In summary, we provide novel evidence for a p53-dependent integration of acute changes of cellular energy status and the metabolic adaptation to starvation. Because of its tumor suppressor function, p53 stabilization by starvation could have implications for both metabolic and oncological diseases of the liver.-Prokesch, A., Graef, F. A., Madl, T., Kahlhofer, J., Heidenreich, S., Schumann, A., Moyschewitz, E., Pristoynik, P., Blaschitz, A., Knauer, M., Muenzner, M., Bogner-Strauss, J. G., Dohr, G., Schulz, T. J., Schupp, M. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis.
Keywords: AMPK; fasting; hepatic steatosis; liver metabolism; nutrient deprivation.
© The Author(s).
Figures
References
- Junttila M. R., Evan G. I. (2009) p53—a Jack of all trades but master of none. Nat. Rev. Cancer 9, 821–829
- Vousden K. H., Prives C. (2009) Blinded by the light: the growing complexity of p53. Cell 137, 413–431
- Muller P. A., Vousden K. H. (2014) Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25, 304–317
- Warburg O. (1956) On the origin of cancer cells. Science 123, 309–314
- Berkers C. R., Maddocks O. D., Cheung E. C., Mor I., Vousden K. H. (2013) Metabolic regulation by p53 family members. Cell Metab. 18, 617–633
- Vousden K. H., Ryan K. M. (2009) p53 and metabolism. Nat. Rev. Cancer 9, 691–700
- Matoba S., Kang J. G., Patino W. D., Wragg A., Boehm M., Gavrilova O., Hurley P. J., Bunz F., Hwang P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650–1653
- Bensaad K., Tsuruta A., Selak M. A., Vidal M. N., Nakano K., Bartrons R., Gottlieb E., Vousden K. H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107–120
- Tschaharganeh D. F., Xue W., Calvisi D. F., Evert M., Michurina T. V., Dow L. E., Banito A., Katz S. F., Kastenhuber E. R., Weissmueller S., Huang C. H., Lechel A., Andersen J. B., Capper D., Zender L., Longerich T., Enikolopov G., Lowe S. W. (2014) p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 158, 579–592; erratum in: Cell (2016) 165, 1546–1547
- Xue W., Zender L., Miething C., Dickins R. A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S. W. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660
- Katz S. F., Lechel A., Obenauf A. C., Begus-Nahrmann Y., Kraus J. M., Hoffmann E. M., Duda J., Eshraghi P., Hartmann D., Liss B., Schirmacher P., Kestler H. A., Speicher M. R., Rudolph K. L. (2012) Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology 142, 1229–1239.e3
- Zhang P., Tu B., Wang H., Cao Z., Tang M., Zhang C., Gu B., Li Z., Wang L., Yang Y., Zhao Y., Wang H., Luo J., Deng C. X., Gao B., Roeder R. G., Zhu W. G. (2014) Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc. Natl. Acad. Sci. USA 111, 10684–10689
- Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A. Jr., Butel J. S., Bradley A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221
- Goldstein I., Yizhak K., Madar S., Goldfinger N., Ruppin E., Rotter V. (2013) p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 1, 9
- Armata H. L., Golebiowski D., Jung D. Y., Ko H. J., Kim J. K., Sluss H. K. (2010) Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol. Cell. Biol. 30, 5787–5794
- Liu Y., He Y., Jin A., Tikunov A. P., Zhou L., Tollini L. A., Leslie P., Kim T. H., Li L. O., Coleman R. A., Gu Z., Chen Y. Q., Macdonald J. M., Graves L. M., Zhang Y. (2014) Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation. Proc. Natl. Acad. Sci. USA 111, E2414–E2422
- Kung C. P., Leu J. I., Basu S., Khaku S., Anokye-Danso F., Liu Q., George D. L., Ahima R. S., Murphy M. E. (2016) The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep. 14, 2413–2425
- Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I. (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15, 1082–1087
- Schupp M., Chen F., Briggs E. R., Rao S., Pelzmann H. J., Pessentheiner A. R., Bogner-Strauss J. G., Lazar M. A., Baldwin D., Prokesch A. (2013) Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues. BMC Genomics 14, 758
- Perry M. E. (2010) The regulation of the p53-mediated stress response by MDM2 and MDM4. Cold Spring Harb. Perspect. Biol. 2, a000968
- Bressac B., Galvin K. M., Liang T. J., Isselbacher K. J., Wands J. R., Ozturk M. (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 1973–1977
- Levitan I. B., Norman J. (1980) Different effects of cAMP and cGMP derivatives on the activity of an identified neuron: biochemical and electrophysiological analysis. Brain Res. 187, 415–429
- Vassilev L. T., Vu B. T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., Fotouhi N., Liu E. A. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844–848
- Wang W., Gallant J. N., Katz S. I., Dolloff N. G., Smith C. D., Abdulghani J., Allen J. E., Dicker D. T., Hong B., Navaraj A., El-Deiry W. S. (2011) Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biol. Ther. 12, 229–238
- Lee J. M., Wagner M., Xiao R., Kim K. H., Feng D., Lazar M. A., Moore D. D. (2014) Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516, 112–115
- Sermeus A., Rebucci M., Fransolet M., Flamant L., Desmet D., Delaive E., Arnould T., Michiels C. (2013) Differential effect of hypoxia on etoposide-induced DNA damage response and p53 regulation in different cell types. J. Cell. Physiol. 228, 2365–2376
- Hardie D. G., Ross F. A., Hawley S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251–262
- Fischer M., Steiner L., Engeland K. (2014) The transcription factor p53: not a repressor, solely an activator. Cell Cycle 13, 3037–3058
- Allen M. A., Andrysik Z., Dengler V. L., Mellert H. S., Guarnieri A., Freeman J. A., Sullivan K. D., Galbraith M. D., Luo X., Kraus W. L., Dowell R. D., Espinosa J. M. (2014) Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. eLife 3, e02200
- Dennis G. Jr., Sherman B. T., Hosack D. A., Yang J., Gao W., Lane H. C., Lempicki R. A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, 3
- Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., Paulovich A., Pomeroy S. L., Golub T. R., Lander E. S., Mesirov J. P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550
- Guan H. P., Goldstein J. L., Brown M. S., Liang G. (2009) Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice. J. Biol. Chem. 284, 24644–24652
- Jones R. G., Plas D. R., Kubek S., Buzzai M., Mu J., Xu Y., Birnbaum M. J., Thompson C. B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283–293
- Imamura K., Ogura T., Kishimoto A., Kaminishi M., Esumi H. (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562–567
- Burgess S. C., He T., Yan Z., Lindner J., Sherry A. D., Malloy C. R., Browning J. D., Magnuson M. A. (2007) Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 5, 313–320
- Goldstein I., Ezra O., Rivlin N., Molchadsky A., Madar S., Goldfinger N., Rotter V. (2012) p53, a novel regulator of lipid metabolism pathways. J. Hepatol. 56, 656–662
- Wang X., Zhao X., Gao X., Mei Y., Wu M. (2013) A new role of p53 in regulating lipid metabolism. J. Mol. Cell Biol. 5, 147–150
- Goldstein I., Rotter V. (2012) Regulation of lipid metabolism by p53—fighting two villains with one sword. Trends Endocrinol. Metab. 23, 567–575
- Liu K., Czaja M. J. (2013) Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ. 20, 3–11
- Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A. M., Czaja M. J. (2009) Autophagy regulates lipid metabolism. Nature 458, 1131–1135
- Maiuri M. C., Galluzzi L., Morselli E., Kepp O., Malik S. A., Kroemer G. (2010) Autophagy regulation by p53. Curr. Opin. Cell Biol. 22, 181–185
- Baquet A., Lavoinne A., Hue L. (1991) Comparison of the effects of various amino acids on glycogen synthesis, lipogenesis and ketogenesis in isolated rat hepatocytes. Biochem. J. 273, 57–62
- Aikawa T., Matsutaka H., Yamamoto H., Okuda T., Ishikawa E. (1973) Gluconeogenesis and amino acid metabolism. II. Inter-organal relations and roles of glutamine and alanine in the amino acid metabolism of fasted rats. J. Biochem. 74, 1003–1017
- Aguilar V., Fajas L. (2010) Cycling through metabolism. EMBO Mol. Med. 2, 338–348
- Fajas L. (2013) Re-thinking cell cycle regulators: the cross-talk with metabolism. Front. Oncol. 3, 4
- Ma W., Sung H. J., Park J. Y., Matoba S., Hwang P. M. (2007) A pivotal role for p53: balancing aerobic respiration and glycolysis. J. Bioenerg. Biomembr. 39, 243–246
- Longo V. D., Mattson M. P. (2014) Fasting: molecular mechanisms and clinical applications. Cell Metab. 19, 181–192
- Schupp M., Cristancho A. G., Lefterova M. I., Hanniman E. A., Briggs E. R., Steger D. J., Qatanani M., Curtin J. C., Schug J., Ochsner S. A., McKenna N. J., Lazar M. A. (2009) Re-expression of GATA2 cooperates with peroxisome proliferator–activated receptor-gamma depletion to revert the adipocyte phenotype. J. Biol. Chem. 284, 9458–9464
- Marino S., Vooijs M., van Der Gulden H., Jonkers J., Berns A. (2000) Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994–1004
- Ristow M., Mulder H., Pomplun D., Schulz T. J., Müller-Schmehl K., Krause A., Fex M., Puccio H., Müller J., Isken F., Spranger J., Müller-Wieland D., Magnuson M. A., Möhlig M., Koenig M., Pfeiffer A. F. (2003) Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest. 112, 527–534
- Cui Q., Lewis I. A., Hegeman A. D., Anderson M. E., Li J., Schulte C. F., Westler W. M., Eghbalnia H. R., Sussman M. R., Markley J. L. (2008) Metabolite identification via the Madison Metabolomics Consortium Database. Nat. Biotechnol. 26, 162–164
- Prokesch A., Pelzmann H. J., Pessentheiner A. R., Huber K., Madreiter-Sokolowski C. T., Drougard A., Schittmayer M., Kolb D., Magnes C., Trausinger G., Graier W. F., Birner-Gruenberger R., Pospisilik J. A., Bogner-Strauss J. G. (2016) N-acetylaspartate catabolism determines cytosolic acetyl-CoA levels and histone acetylation in brown adipocytes. Sci. Rep. 6, 23723
- Wilson C. G., Schupp M., Burkhardt B. R., Wu J., Young R. A., Wolf B. A. (2010) Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice. Endocrinology 151, 5174–5184
Source: PubMed